COVID-19 rapid test KaiBiLi™

proteinfor antigenscoronavirus

This COVID-19 Antigen - Saliva Swab Rapid Test Device is designed for testing freshly collected saliva samples, for the qualitative detection of 2019 Novel Coronavirus nucleocapsid protein antigens in saliva. Introduction SARS-CoV-2 antigen rapid diagnostic tests (Ag-RDT) are being used globally to test suspect COVID-19 cases in contexts where PCR diagnostic may not be available, often at subnational level.   COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main symptoms including manifestations include fever, fatigue and dry cough, nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases. Individual factors can contribute to SARS-CoV-2 transmission ● People infected with SARS-CoV-2 can transmit virus with or without symptoms ● Most infected people transmit the virus around 2 days before they develop symptoms and up to 9-10 days after symptom onset ● People who develop severe disease can be infectious for longer ● Immunocompromised people can shed the virus for months ● Symptomatic persons infected with SARS-CoV-2 are 3 to 18 times more likely to transmit the virus than asymptomatic persons. Detection The qualitative detection of 2019 Novel Coronavirus nucleocapsid protein antigens in saliva. Limit Of Detection (LoD) SARS-CoV-2:140TCID50/mL Accuracy Positive Percent Agreement: 96.5%